Table 3 BAL parameters
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Normal range | |
|---|---|---|---|---|---|---|
Total cells (x 105/ml) | 1,8 | 1,8 | 2,5 | 1,5 | 1,3 | |
Macrophages | 78% | 80% | 77% | 72% | 66% | 75–85% |
Neutrophils | 0 | 0 | 5% | 3% | 2% | 1–2% |
Lymphocytes | 22% | 20% | 26% | 24% | 30% | 8–12% |
Eosinophils | 0 | 0 | 2% | 1% | 2% | 0–0,5% |
T CD3+ | 99% | 95.8% | 96% | 95% | 93% | 70–90% |
T CD4+ | 35% | 17.2% | 41% | 38% | 39% | 35–45% |
T CD8+ | 60.3% | 77% | 52% | 47% | 50% | 30–40% |
Natural killer CD3-CD16 + CD56+ | 0,70% | 2,60% | 3% | 2% | 3% | 1–7% |
B CD19+ | 0 | 0,50% | 1% | 1% | 1% | 0–7% |
CD4/CD8 RATIO | 0.6 | 0,2 | 0,7 | 0,8 | 0,7 | 0,8–2 |
CD3 + HLA-DR+ | 25.8% | 36% | 31% | 24% | 13% |